## VMC: Vulcan Materials Company (Holdi - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -0.7% below STRENGTH zone (4.0-10.0%); PEG 2.23 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($275.34)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. A Look Into Vulcan Materials Inc's Price Over Earnings**
- Source: Sahm | 20251218T011052 | Neutral | Relevance: 97%
- Vulcan Materials Inc. stock has increased by 5.63% over the past month and 8.82% over the past year. The company's P/E ratio is lower than the Construction Materials industry average of 39.27, which could suggest undervaluation or potentially weaker future performance. The article emphasizes that the P/E ratio is just one metric among many that investors should consider for a comprehensive analysis.

**2. Peruvian Cement Stock Cementos Pacasmayo Skyrockets After Holcim Move**
- Source: Benzinga | 20251216T160841 | Somewhat-Bullish | Relevance: 62%
- Cementos Pacasmayo S.A.A. (NYSE: CPAC) stock surged on Tuesday after Holcim Ltd. agreed to acquire its controlling shareholder, Inversiones Aspi S.A., which owns 50.01% of Cementos Pacasmayo. The deal, valued at approximately $1.4 billion, is expected to enhance Cementos Pacasmayo's growth and international reach. The acquisition is subject to regulatory approvals and is projected to close in the first half of 2026.

**3. Invesco Main Street Mid Cap Fund Q3 2025 Commentary (Mutual Fund:OPMSX)**
- Source: Seeking Alpha | 20251217T044734 | Somewhat-Bullish | Relevance: 60%
- The Invesco Main Street Mid Cap Fund Class A (OPMSX) underperformed its benchmark, the Russell Midcap Index, in Q3 2025, returning 4.11% against the index's 5.33%. This underperformance was primarily due to stock selection in the industrials, consumer staples, and healthcare sectors. The fund maintains a strategy of investing in well-managed companies with strong balance sheets and competitive positioning, emphasizing valuation discipline and skilled management.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.59M) |
| Sells | 9 ($7.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (+1.8%)
- JPMORGAN CHASE & CO: 12.0% (+102.5%)
- State Farm Mutual Au: 7.2% (0.0%)
- Blackrock Inc.: 6.9% (-1.6%)
- Principal Financial : 5.8% (+5.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.2% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $7.5M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.23 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (2.2x). Insider selling cluster ($7.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.1B |
| Beta | 1.06 |
| 52W Range | $215.08 - $311.74 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.23 |
| Forward P/E | 29.3 |
| Current P/E | 34.2 |
| YoY Growth | 16.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.4% to -0.7% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.7pp (needs >4.0% for momentum thesis). Underperforming sector by 3.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.05x) but short-term weakness (below SMA20). MACD histogram bearish (-0.58), momentum weakening. RSI neutral at 45. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.74% (CS: 34) | Neutral |
| RSI_14 | 45.3 | Neutral |
| MACD Histogram | -0.58 | Bearish |
| vs SMA20 | 0.986x | Below |
| vs SMA50 | 0.986x | Below |
| vs SMA200 | 1.053x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $288.26
- **Stop Loss:** $275.34 (4.5% risk)
- **Target:** $301.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 88
- **Position Value:** $25,366.88
- **Portfolio %:** 25.37%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-18 (Est: $2.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.72 | $2.84 | +4.4% |
| 2025Q2 | $2.52 | $2.45 | -2.8% |
| 2025Q1 | $0.76 | $1.00 | +31.6% |
| 2024Q4 | $1.75 | $2.17 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*